Try our mobile app

Optinose to Present at the Piper Jaffray 31st Annual Healthcare Conference

Published: 2019-11-26 21:01:00 ET
<<<  go to OPTN company page

YARDLEY, Pa., Nov. 26, 2019 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present a company overview and business update at the Piper Jaffray 31st Annual Healthcare Conference on Tuesday, December 3, 2019 at 3:00 p.m. ET.  

To listen to a webcast of this presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 30 days following the conclusion of the event.

About OptinoseOptinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has offices in the U.S., the U.K. and Norway. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.  

Optinose Investor ContactJonathan Neelyjonathan.neely@optinose.com267.521.0531

Optinose_logo_RGB.png

Source: Optinose, Inc.